Editas Medicine, Inc. (EDIT) Form 10-Q Quarterly Reports
Editas Medicine, Inc. (EDIT) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: EDIT
CIK: 1650664
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerChristopher Pereira
Audit LocationBoston, Massachusetts, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-10-08 | 2026-10-08 | 8-K | 0001650664-26-000093 | View SEC Doc Filr Page |
| 4 | 2026-09-09 | 2026-09-08 | FORM 4 | 0002149618-26-000006 | View SEC Doc Filr Page |
| 3 | 2026-09-09 | 2026-09-08 | FORM 3 | 0002149618-26-000005 | View SEC Doc Filr Page |
| S-8 | 2026-09-09 | — | S-8 | 0001650664-26-000090 | View SEC Doc Filr Page |
| EFFECT | 2026-09-08 | — | EFFECT Filing | 9999999995-26-002915 | View SEC Doc Filr Page |
| 4 | 2026-09-04 | 2026-09-03 | FORM 4 | 0001985604-26-000003 | View SEC Doc Filr Page |
| 4 | 2026-09-04 | 2026-09-03 | FORM 4 | 0002063082-26-000006 | View SEC Doc Filr Page |
| 4 | 2026-09-04 | 2026-09-03 | FORM 4 | 0001742084-26-000003 | View SEC Doc Filr Page |
| S-3 | 2026-08-31 | — | S-3 | 0001104659-26-103906 | View SEC Doc Filr Page |
| 144 | 2026-08-31 | — | 144 Filing | 0001650664-26-000087 | View SEC Doc Filr Page |
| 144 | 2026-08-31 | — | 144 Filing | 0001650664-26-000085 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-14 | — | SCHEDULE 13G Filing | 0001104659-26-097420 | View SEC Doc Filr Page |
| 4 | 2026-08-07 | 2026-08-06 | FORM 4 | 0002137699-26-000004 | View SEC Doc Filr Page |
| 3 | 2026-08-07 | 2026-08-06 | FORM 3 | 0002137699-26-000003 | View SEC Doc Filr Page |
| 4 | 2026-08-05 | 2026-08-03 | FORM 4 | 0002063082-26-000003 | View SEC Doc Filr Page |
| 10-Q | 2026-08-05 | 2026-06-30 | 10-Q | 0001650664-26-000083 | View SEC Doc Filr Page |
| 8-K | 2026-08-05 | 2026-08-03 | 8-K | 0001650664-26-000082 | View SEC Doc Filr Page |
| 4 | 2026-07-29 | 2026-07-28 | FORM 4 | 0001650664-26-000076 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-07-29 | — | SCHEDULE 13G/A Filing | 0002012383-26-002798 | View SEC Doc Filr Page |
| 144 | 2026-07-21 | — | 144 Filing | 0001650664-26-000074 | View SEC Doc Filr Page |
| 4 | 2026-06-22 | 2026-06-17 | FORM 4 | 0001650664-26-000072 | View SEC Doc Filr Page |
| 4 | 2026-06-22 | 2026-06-17 | FORM 4 | 0001650664-26-000071 | View SEC Doc Filr Page |
| 4 | 2026-06-22 | 2026-06-17 | FORM 4 | 0001650664-26-000070 | View SEC Doc Filr Page |
| 4 | 2026-06-22 | 2026-06-17 | FORM 4 | 0001650664-26-000069 | View SEC Doc Filr Page |
| 4 | 2026-06-22 | 2026-06-17 | FORM 4 | 0001650664-26-000068 | View SEC Doc Filr Page |